Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06239896 · ClinicalTrials.gov registry record · NA

Advance Care Planning With Formerly Homeless Older Adults Residing in Permanent Supportive Housing

A NA study of Advance Care Planning, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
650
Enrollment target
6
Study locations

NCT06239896: Recruiting NA study of Advance Care Planning, sponsored by University of California, San Francisco.

NCT06239896 is a NA study of Advance Care Planning that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 650 participants, above the 438-participant average among 9 other Advance Care Planning trials with a reported enrollment target (48% higher). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06239896, a NA study of Advance Care Planning, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
650 participants
Enrollment target
6
Study locations

Study Summary

The homeless population is aging, with an increasing proportion of individuals over age 50 who experience accelerated aging, high rates of mortality, and a high risk of not having their wishes honored at the end of life. The goal of this randomized control trial (RCT) is to test the effectiveness of adapted evidence-based advance care planning (ACP) interventions for formerly chronically homeless older adults living in permanent supportive housing (PSH).

Primary Outcome

Our primary analyses will compare change in engagement using the 9-item ACP Engagement Survey average 5-point Likert scores from baseline to 3 and 6 months between study arms (groups vs. one-on-one sessions).

Conditions Studied

Interventions

  • BEHAVIORAL Facilitated Group ACP Session
  • BEHAVIORAL Facilitated one-on-one ACP visits

Study Locations (6)

California

  • Abode Services - Fremont
  • Lifelong Medical Care - Oakland
  • Mercy Housing - San Francisco
  • Delivering Innovation in Supportive Housing (DISH) - San Francisco
  • Episcopal Community Services - San Francisco
  • HomeRise - San Francisco

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2024-03-06
Est. Completion 2027-03
Phase NA

What NCT06239896 shows while recruiting

NCT06239896 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, above the 438-participant average among 9 other Advance Care Planning trials with a reported enrollment target (48% higher).

The record links to 1 condition, with Advance Care Planning appearing as the primary indexed condition, and to 2 interventions - of which Facilitated Group ACP Session is the first listed.

NCT06239896 lists 6 locations in 1 state (California).

Frequently Asked Questions

What is clinical trial NCT06239896 about?

NCT06239896 is a clinical study titled "Advance Care Planning With Formerly Homeless Older Adults Residing in Permanent Supportive Housing". The homeless population is aging, with an increasing proportion of individuals over age 50 who experience accelerated aging, high rates of mortality, and a high risk of not having their wishes honored at the end of life. The goal of this randomized control trial (RCT) is to test the effectiveness of...

What is the current status of trial NCT06239896?

This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2024-03-06. Estimated completion is 2027-03.

What conditions does trial NCT06239896 study?

This clinical trial studies the following conditions: Advance Care Planning.

What interventions are being tested in trial NCT06239896?

The interventions under investigation include: Facilitated Group ACP Session (BEHAVIORAL), Facilitated one-on-one ACP visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT06239896?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06239896 being conducted?

This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advance Care Planning

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06239896's enrollment target sits among peer trials

650 3rd of 9 higher than 7 of 9 other Advance Care Planning trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advance Care Planning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06239896, the US trial registry maintained by the National Library of Medicine. NCT06239896 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.